Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$114M Sell
452,394
-69,972
-13% -$15.1M 0.56% 35
2026
Q1
$114M Sell
522,366
-268,669
-34% -$59.6M 0.69% 25
2025
Q4
$181M Sell
791,035
-130,466
-14% -$29.7M 1.09% 17
2025
Q3
$213M Buy
921,501
+528,196
+134% +$108M 1.15% 17
2025
Q2
$73M Sell
393,305
-146,992
-27% -$27.3M 0.44% 38
2025
Q1
$113M Sell
540,297
-58,038
-10% -$11.3M 0.79% 25
2024
Q4
$106M Buy
598,335
+263,557
+79% +$48.5M 0.72% 24
2024
Q3
$66.1M Sell
334,778
-96,568
-22% -$18M 0.38% 44
2024
Q2
$74M Sell
431,346
-4,312
-1% -$714K 0.44% 44
2024
Q1
$79.3M Buy
435,658
+171,224
+65% +$29.5M 0.54% 34
2023
Q4
$41M Sell
264,434
-39,234
-13% -$5.72M 0.33% 58
2023
Q3
$45.3M Sell
303,668
-112,553
-27% -$16.5M 0.4% 53
2023
Q2
$56.1M Sell
416,221
-225,021
-35% -$33M 0.43% 49
2023
Q1
$102M Buy
641,242
+234,509
+58% +$35.9M 0.99% 20
2022
Q4
$65.7M Sell
406,733
-38,610
-9% -$5.92M 0.66% 30
2022
Q3
$59.8M Buy
445,343
+49,083
+12% +$7.04M 1% 23
2022
Q2
$60.7M Buy
396,260
+115,813
+41% +$17.7M 0.7% 27
2022
Q1
$45.5M Buy
280,447
+50,510
+22% +$7.34M 0.46% 47
2021
Q4
$31.1M Buy
229,937
+6,506
+3% +$769K 0.28% 73
2021
Q3
$24.1M Buy
223,431
+78,301
+54% +$8.95M 0.31% 57
2021
Q2
$16.3M Buy
145,130
+27,866
+24% +$3.14M 0.26% 65
2021
Q1
$12.7M Sell
117,264
-619
-0.5% -$66.2K 0.26% 65
2020
Q4
$12.6M Buy
117,883
+77,319
+191% +$7.43M 0.28% 60
2020
Q3
$3.55M Buy
40,564
+24,153
+147% +$2.27M 0.15% 91
2020
Q2
$1.61M Buy
16,411
+8,745
+114% +$770K 0.07% 95
2020
Q1
$584K Sell
7,666
-13,615
-64% -$1.16M 0.03% 240
2019
Q4
$1.88M Sell
21,281
-71,836
-77% -$5.96M 0.06% 211
2019
Q3
$7.05M Sell
93,117
-128,835
-58% -$8.83M 0.18% 99
2019
Q2
$16.1M Sell
221,952
-4,893
-2% -$385K 0.28% 73
2019
Q1
$18.3M Buy
226,845
+183,863
+428% +$15M 0.4% 50
2018
Q4
$3.96M Sell
42,982
-6,490
-13% -$571K 0.09% 150
2018
Q3
$4.68M Buy
+49,472
New +$4.69M 0.08% 165
2018
Q2
Sell
-351,320
Closed -$33.3M 720
2018
Q1
$33.3M Buy
351,320
+319,305
+997% +$35.1M 0.6% 36
2017
Q4
$3.1M Sell
32,015
-33,679
-51% -$3.17M 0.05% 174
2017
Q3
$5.84M Sell
65,694
-72,809
-53% -$5.54M 0.11% 135
2017
Q2
$10M Buy
+138,503
New +$9.31M 0.19% 78
2016
Q3
Sell
-1,343,553
Closed -$83.2M 567
2016
Q2
$83.2M Buy
+1,343,553
New +$81.9M 1.12% 23
2016
Q1
Sell
-875,477
Closed -$51.9M 529
2015
Q4
$51.9M Buy
875,477
+475,976
+119% +$27.4M 0.31% 80
2015
Q3
$21.7M Sell
399,501
-201,019
-33% -$13.1M 0.15% 136
2015
Q2
$40.3M Sell
600,520
-802,274
-57% -$52.4M 0.22% 97
2015
Q1
$82.1M Sell
1,402,794
-222,699
-14% -$13.5M 0.41% 54
2014
Q4
$106M Buy
1,625,493
+161,449
+11% +$10.2M 0.5% 40
2014
Q3
$84.6M Buy
1,464,044
+187,812
+15% +$10.4M 0.49% 43
2014
Q2
$72M Sell
1,276,232
-140,536
-10% -$7.37M 0.36% 58
2014
Q1
$72.8M Sell
1,416,768
-143,631
-9% -$7.26M 0.38% 55
2013
Q4
$82.4M Buy
1,560,399
+487,824
+45% +$24M 0.41% 58
2013
Q3
$48M Sell
1,072,575
-325,298
-23% -$14.4M 0.24% 103
2013
Q2
$57.8M Buy
+1,397,873
New +$61.1M 0.31% 89

Other funds holding ABBV

ING Group's ABBV Position: Q2 2026 in Review

ING Group reduced its AbbVie (ABBV) stake by 13% in Q2 2026, selling an estimated $15.1M and leaving 452,394 shares worth $114M. The position accounts for 0.56% of the portfolio, ranked #35.

ING Group first reported a position in ABBV in Q2 2013 and has held it in 48 quarters since. The position peaked at $213M in Q3 2025. 4,187 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • ING Group held 452,394 shares of AbbVie worth $114M as of Q2 2026.
  • ING Group sold 69,972 AbbVie shares in Q2 2026, an estimated $15.1M.
  • AbbVie made up 0.56% of ING Group's portfolio in Q2 2026, its #35 holding.
  • ING Group first reported a position in AbbVie in Q2 2013 and has held it in 48 quarters since.
  • ING Group's AbbVie position peaked at $213M in Q3 2025.
  • 4,187 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on ING Group's 13F filing for Q2 2026, filed 13 Aug 2026.